Proxy Votes Now

Home › Funds › Morgan Stanley › Morgan Stanley Europe Opportunity Fund Inc.

Morgan Stanley Europe Opportunity Fund Inc. (EUGAX) proxy voting record 2025-2026

Fund family: Morgan Stanley · Filed by Morgan Stanley Europe Opportunity Fund Inc. (CIK 860720) · SEC series S000002387

Share classes and tickers: EUGAX (C000006316), EUGCX (C000006318), EUGDX (C000006319), MSEEX (C000155977)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 334 with, 0 against, 0 abstentions (not counted as with management); 9 items carried no recommendation. Shareholder proposals: 3 FOR, 1 AGAINST, 5 abstained, by the filing’s own vote-source field.

Compared with Morgan Stanley as a whole

The same two figures as Morgan Stanley’s manager page (139,958 ballot items across 61 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsMorgan StanleyItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)99.3%27286.0%111,214
Backed environmental and social shareholder proposals at US companiesn/a027.9%1,130

Where this fund voted differently from most Morgan Stanley funds

Each ballot item this fund voted is set against the votes of the other Morgan Stanley funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Morgan Stanley funds on 18 items (5.9% of the 306 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Morgan Stanley fundsMgmtResult
London Stock Exchange Group plc2026-04-23Authorise the Company to Call General Meeting with Two Weeks' NoticeForAGAINST — 5 of 6 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New TransactionsForAGAINST — 5 of 8 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Approve Compensation Report of Corporate OfficersForAGAINST — 5 of 8 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Approve Compensation of Bernard Arnault, Chairman and CEOForAGAINST — 5 of 8 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Approve Remuneration Policy of Chairman and CEOForAGAINST — 5 of 8 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Reelect Laurent Mignon as DirectorForAGAINST — 5 of 8 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Reelect Marie-Josee Kravis as DirectorForAGAINST — 5 of 8 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Reelect Natacha Valla as DirectorForAGAINST — 5 of 8 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Renew Appointment of Diego Della Valle as CensorForAGAINST — 5 of 8 Morgan Stanley fundsFor—
LVMH Moet Hennessy Louis Vuitton SE2026-04-23Renew Appointment of Lord Powell of Bayswater as CensorForAGAINST — 5 of 8 Morgan Stanley fundsFor—
Novo Nordisk A/S2025-11-14Shareholder Elect Britt Meelby Jensen as New DirectorAbstainFOR — 3 of 4 Morgan Stanley funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Cees de Jong (Vice Chair) as New DirectorAbstainFOR — 3 of 4 Morgan Stanley funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Lars Rebien Sorensen (Chair) as New DirectorAbstainFOR — 3 of 4 Morgan Stanley funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Mikael Dolsten as New DirectorAbstainFOR — 3 of 4 Morgan Stanley funds——
Novo Nordisk A/S2025-11-14Shareholder Elect Stephan Engels as New DirectorAbstainFOR — 3 of 4 Morgan Stanley funds——
London Stock Exchange Group plc2026-04-23Approve Remuneration ReportForAGAINST — 4 of 6 Morgan Stanley fundsFor—
On Holding AG2026-05-28Transact Other Business (Voting)ForAGAINST — 4 of 7 Morgan Stanley fundsFor—
Wise Plc2025-09-25Approve Remuneration ReportForAGAINST — 3 of 5 Morgan Stanley fundsFor—

Download all 18 differences (CSV)

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections1430
Compensation630
Corporate Governance610
Capital Structure520
Audit-related190
Extraordinary Transactions30
Other Social Issues20

Search this fund’s votes by company

343 ballot items at 20 meetings in 2025-2026. Download all votes (CSV)

About this fund’s record

In the 2025-2026 proxy season, Morgan Stanley Europe Opportunity Fund Inc. (EUGAX) voted at 20 shareholder meetings of 17 companies, on 343 ballot items in all. Where management made a recommendation, the fund followed it on 100.0% of the items and voted against it 0 times. It voted on 9 shareholder proposals. It voted FOR the board's own proposals more often than Morgan Stanley's funds as a whole (99.3% against 86.0%). It voted differently from most Morgan Stanley funds on 18 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Morgan Stanley’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.